HHS Allocates Gilead ' s COVID-19 Drug Remdesivir to Four Hardest Hit States HHS Allocates Gilead ' s COVID-19 Drug Remdesivir to Four Hardest Hit States

The US   government has allocated more than 11,000 courses of Gilead ' s COVID-19 treatment remdesivir to the four states now being hardest hit by the fast-spreading outbreak in the US.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news